Quaker Partners

Description

Quaker Partners is an East Coast-focused healthcare investment firm. The funds that we manage pursue a traditional venture capital strategy, leading equity investments in healthcare companies at all stages of development. Our industry expertise includes pharmaceuticals, biotechnology, healthcare services, and medical technologies such as devices, tools and human diagnostics. Since its founding in 2002, Quaker has invested in dozens of innovative, high impact healthcare companies. Quaker manages over $700 million in committed capital, and is currently investing its second fund.

Quaker Partners is a Philadelphia-based healthcare venture capital firm managing over $700 million in committed capital, investing in pharmaceuticals, biotechnology, medical devices, and diagnostics companies at all stages — it does not acquire or back healthcare services platforms or dental practices.

Quaker Partners is a traditional venture capital firm investing in early-to-late stage healthcare product companies (pharmaceuticals, biotechnology, medical devices, diagnostics) — not a buyer or platform acquirer of healthcare services practices; it is a pure product-focused VC, not a pe_sponsor with a services-platform buyout mandate.

enriched 2026-05-05

Financials